Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,161.2
-5.7 (-0.18%)

 

  • STI Straits Times Index
    3,161.2
    -5.7 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.0
    -1.6 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,235.8
    274.8 (1.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,464.3
    66.9 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,781.0
    497.4 (1.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,096.5
    26.5 (0.44%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,145.9M
  • Value: 1,099.4M
  • Rise: 166
  • Fall: 177
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.116+0.001
Rex Intl0.235+0.025
Abundance Intl0.046+0.004
Raffles Edu0.080-0.020
Genting Sing0.805-0.005
Mercurius0.057-0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
ISDN0.810+0.045
ThaiBev0.645-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,235.8 +274.8
HSCEI 9,336.6 +103.4
Jakarta 6,096.5 +26.5
Nikkei 225 27,781.0 +497.4
SSE Comp 3,464.3 +66.9
Shanghai A 3,630.9 +70.2
Shanghai B 257.6 +3.6
KOSPI 3,223.0 +20.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WEREWOLF THERAPEUTICS INC WEREWOLF THERAPEUTICS
Updated on 30 Jul 2021 (End of trading day)
Last (USD): 17.420 Change: -0.250 High: 18.110 Remarks: -
Change (%): -1.41 Low: 17.010
Open 17.350 Yesterday's Close 17.67
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 20,637 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.02356 Trailing EPS (USD) e -1.02356 NAV (USD) b -5.5773
PE a - Trailing PE f - Price / NAV b -3.1234
Dividend (USD) d - Cash In Hand (USD) g 3.0689 Issued & Paid-up Shares c 27,567,600
Dividend Yield (%) d - Price / Cash In Hand g 5.676 Treasury Shares h -
Market Cap (M) 480.228 Enterprise Value (M) 634.106
Piotroski F Score 3 Exchange Code HOWL Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 45.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 28 Apr 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WEREWOLF THERAPEUTICS INC NASDAQ 480.228 - - -3.1234 -
Industry Pharmaceuticals: Major NASDAQ 2,391.520 87.484 91.614 8.4845 1.397
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 177,342.685 55.061 54.624 - 2.028
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,276.652 9.281 36.392 - 2.594
Local Peer ROYALTY PHARMA PLC NASDAQ 23,191.678 23.785 23.840 4.7502 0.502
Local Peer VIATRIS INC NASDAQ 17,005.846 - - 0.7941 -
Local Peer REPLIGEN CORP NASDAQ 13,507.898 225.409 135.170 8.4263 -
Local Peer CUREVAC NV NASDAQ 9,173.197 - - - -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 7,267.207 - - 7.3797 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,352.760 - - 6.7328 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,223.515 - - 30.1436 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 6,009.240 88.078 88.078 6.9838 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 5,150.990 - - 99.7195 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,545.977 - - 12.3086 -
Other Local Peers ALLAKOS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), PETIQ INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GH RESEARCH PLC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ESSA PHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ANNEXON INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), EVOLUS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), PHARVARIS NV (NASDAQ), VERU INC (NASDAQ), AC IMMUNE SA (NASDAQ), CLENE INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), BEYONDSPRING INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), DURECT CORP (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), 89BIO INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), NEXIMMUNE INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), VINCERX PHARMA INC (NASDAQ), IMMUNIC INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), OBSEVA SA (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), IMARA INC (NASDAQ), GENPREX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), NOVAN INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), PROPHASE LABS INC (NASDAQ), GALECTO INC (NASDAQ), MEDIWOUND LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GRAYBUG VISION INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), MANNATECH INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 453,313.056 30.808 25.514 6.5150 2.311
Global Peer PFIZER INC NYSE 239,637.109 24.921 18.116 - 3.554
Global Peer ELI LILLY AND COMPANY NYSE 233,522.831 37.703 38.330 33.8505 1.213
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 224,916.064 27.698 25.007 4.1619 2.086
Global Peer ABBVIE INC NYSE 205,411.386 45.086 40.403 14.9827 4.159
Global Peer MERCK & CO INC NYSE 194,639.452 27.542 48.346 - 3.224
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 164,139.056 25.472 24.416 17.7561 1.453
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 150,814.606 - - 4.0973 2.738
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 100,985.818 13.698 17.026 4.7540 5.155
Global Peer WUXI APPTEC HKEx 486,881.631 146.691 102.198 11.6306 0.213
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM (HKEx), HUTCHMED (HKEx), ORGANON & CO (NYSE), REMEGEN-B (HKEx), HYGEIA HEALTH (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), AKESO-B (HKEx), CMS (HKEx), INNOCARE-B (HKEx), BAIYUNSHAN PH (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINARES PHARMA (HKEx), SIMCERE PHARMA (HKEx), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), EVEREST MED-B (HKEx), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), CARSGEN-B (HKEx), SSY GROUP (HKEx), HEPALINK (HKEx), OCUMENSION-B (HKEx), ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), UNITED LAB (HKEx), ANTENGENE-B (HKEx), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), Kimia Farma Tbk. (IDX), CKLIFE SCIENCES (HKEx), SCICLONE PHARMA (HKEx), SHINEWAY PHARM (HKEx), ZHAOKE OPHTH-B (HKEx), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), STARPHARMA HOLDINGS LIMITED (ASX), IGBB (Bursa), PYC THERAPEUTICS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), DAWNRAYS PHARMA (HKEx), AFT PHARMACEUTICALS LTD (ASX), TOT BIOPHARM-B (HKEx), BSTEAD (Bursa), ANNOVIS BIO INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), FUSEN PHARM (HKEx), LANNETT CO INC (NYSE), IP (SET), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), NOXOPHARM LTD (ASX), IX Biopharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), CRESO PHARMA LTD (ASX), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), NC HEALTHCARE (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), Hyphens Pharma (SGX), NOVA (Bursa), INVION LTD (ASX), MODERN CHI MED (HKEx), BIOHLDG (Bursa), EXOPHARM LTD (ASX), NEP INTERLONG (HKEx), AGEX THERAPEUTICS INC (NYSE American), MEDLAB CLINICAL LIMITED (ASX), WAI YUEN TONG (HKEx), PALLA PHARMA LTD (ASX), TBG DIAGNOSTICS LTD (ASX), PURAPHARM (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), EXTRAWELL PHAR (HKEx), PHARMAXIS (ASX), JCT (SET), SUNZEN (Bursa), TALI DIGITAL LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), IMMURON LIMITED (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), SUDA PHARMACEUTICALS LTD (ASX), ISLAND PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.030
-10.44 %
10 Days -+0.610
+3.63 %
20 Days --2.890
-14.23 %
Medium Term Return 3 Months -+1.160
+7.13 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.230 - 23.990 Change From 1 Year Low +6.190 % Change From 1 Year Low (%) +55.12
Change From 1 Year High -6.570 % Change From 1 Year High (%) -27.39
2 Years Range 11.230 - 23.990 Change From 2 Years Low +6.190 % Change From 2 Years Low (%) +55.12
Change From 2 Years High -6.570 % Change From 2 Years High (%) -27.39
5 Years Range 11.230 - 23.990 Change From 5 Years Low +6.190 % Change From 5 Years Low (%) +55.12
Change From 5 Years High -6.570 % Change From 5 Years High (%) -27.39
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Werewolf Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Jul 2021 17.350 18.110 17.010 17.420 20,637 -
29 Jul 2021 18.790 18.790 17.500 17.670 28,897 -
28 Jul 2021 18.935 18.970 18.230 18.480 41,886 -
27 Jul 2021 19.360 19.480 18.653 18.860 39,520 -
26 Jul 2021 18.420 19.570 18.420 19.450 48,717 -
23 Jul 2021 19.740 19.740 18.180 18.310 38,793 -
22 Jul 2021 19.530 21.670 19.530 19.990 117,473 -
21 Jul 2021 19.230 20.320 19.050 19.820 52,664 -
20 Jul 2021 16.900 19.980 16.900 19.820 119,519 -
19 Jul 2021 15.710 16.899 14.160 16.810 25,274 -
16 Jul 2021 15.820 15.990 15.527 15.890 32,116 -
15 Jul 2021 15.560 16.127 15.245 15.710 47,366 -
14 Jul 2021 15.510 15.680 14.750 15.200 63,510 -
13 Jul 2021 15.730 16.825 15.350 15.420 33,012 -
12 Jul 2021 14.960 16.020 14.960 15.740 42,153 -
09 Jul 2021 15.370 15.490 14.850 14.870 34,351 -
08 Jul 2021 16.530 16.530 15.010 15.390 34,118 -
07 Jul 2021 17.460 17.500 15.580 15.670 37,629 -
06 Jul 2021 20.680 20.749 17.100 17.430 119,043 -
02 Jul 2021 19.200 20.870 19.000 20.310 113,212 -
01 Jul 2021 17.500 19.480 17.261 19.230 195,955 -
30 Jun 2021 16.000 17.490 15.885 17.440 234,538 -
Summary
Current 2 Weeks
(19 Jul 2021 to 30 Jul 2021)
15.710 21.670 14.160 17.420 533,380 -
Previous 2 Weeks
(02 Jul 2021 to 16 Jul 2021)
19.200 21.670 14.160 15.890 556,510 -
4 Weeks from
(04 Jun 2021 to 01 Jul 2021)
12.830 21.670 12.360 19.230 3,431,702 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.